iKang Healthcare Group Inc (NASDAQ:KANG) saw a significant drop in short interest in December. As of December 29th, there was short interest totalling 357,637 shares, a drop of 49.5% from the December 15th total of 707,528 shares. Based on an average daily trading volume, of 288,908 shares, the short-interest ratio is currently 1.2 days. Approximately 0.5% of the company’s stock are sold short.

Shares of iKang Healthcare Group (KANG) opened at $15.74 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.78 and a debt-to-equity ratio of 0.22. iKang Healthcare Group has a 52-week low of $11.70 and a 52-week high of $18.41. The company has a market capitalization of $1,093.02, a PE ratio of 262.33 and a beta of 0.30.

A number of analysts have weighed in on the company. TheStreet upgraded iKang Healthcare Group from a “d+” rating to a “c” rating in a research note on Friday, December 15th. BidaskClub upgraded iKang Healthcare Group from a “hold” rating to a “buy” rating in a research report on Friday, December 22nd.

Institutional investors and hedge funds have recently bought and sold shares of the company. Fosun International Ltd increased its position in shares of iKang Healthcare Group by 40.2% during the third quarter. Fosun International Ltd now owns 3,571,138 shares of the medical research company’s stock worth $48,139,000 after purchasing an additional 1,023,199 shares in the last quarter. Pictet Asset Management Ltd. acquired a new stake in shares of iKang Healthcare Group during the third quarter worth about $330,000. Maso Capital Partners Ltd increased its position in shares of iKang Healthcare Group by 8.7% during the third quarter. Maso Capital Partners Ltd now owns 1,504,062 shares of the medical research company’s stock worth $20,275,000 after purchasing an additional 120,655 shares in the last quarter. GLG Partners LP increased its position in shares of iKang Healthcare Group by 15.5% during the second quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock worth $21,529,000 after purchasing an additional 235,056 shares in the last quarter. Finally, FIL Ltd increased its position in shares of iKang Healthcare Group by 45.4% during the second quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock worth $4,429,000 after purchasing an additional 112,615 shares in the last quarter. Institutional investors and hedge funds own 33.08% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “iKang Healthcare Group Inc (KANG) Short Interest Down 49.5% in December” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/14/ikang-healthcare-group-inc-kang-short-interest-down-49-5-in-december.html.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.